Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

186 Tokyo * transvestites

12th World AIDS Conference

- Keyword Abstract -
s in depressed areas of Tondo community/Establishment-based 23548
at Clinica Remedios in community/Health seeking behavi 60759
mercial sex workers in Manila, Philippines/Health and bea 60990
of behaviour among the Tonga of Southern Province, Zambia/The 14248
g injection drug users in Toronto, Canada/A decade of HIV preven 23190
e and family medicine in, Canada/HIV primary-care and fa 60121
ho have sex with men at bathhouses/Harm reduction amo 60709
osexual perspective in, Canada/Triumphs and tribulatio 60955
-1 disease/Influence of toxic factors on plasma viral load in patient 60264
atients/Tolerability and toxicity of protease inibitor, containing regi 12242
Long-term efficacy and of antiretroviral combination treat 12312
atients/Response and of interferon (IFN) a-2a treatment i 32116
liefs about efficacy and /Antiretroviral uptake in Australia: 32318
megaloviral activity and studies of (-)-2-(S)-dihydroxypho 60291
ctivity of interleukin-4 toxin in nude mice implanted with AIDS-as 22279
ession in CD4+ tetanus toxoid specific T cells/Effect of HIV-1 infec 31141
PCR/Necropsy-proven Toxoplasma ecephalitis without evident fo 60647
dia/Seroprevalence of toxoplasma amongst HIV infected individ 60091
1 SPECT scanning and serology for presumptive diag 60275
pneumonia (PCP) and toxoplasmic encephalitis (TE)/A randomi 22181
s for PCP and cerebral toxoplasmosis be safely discontinued in 12268
rebral or extracerebral occurrence in a cohort of 1 13184
-term serologic study of in HIV patients/Long-term 22231
ence and risk factors of in a French cohort of HIV-i 22234
nfection with Chlamydia trachomatis in Coventry, UK 1992-1996/ 23373
N. gonorrhoeae and C. infections and behavioural pa 60783
cy in reducing perinatal tranmission of HIV-1/Impact of treatment 60900
e US-Mexico border/A trans-border case management and client 34209
nland South-East Asia/ Trans-national population movement and 44202
ry regions by HIV-1 Tat: Transactivation mechanisms of HPV-16 I 31223
-infection and elevated transaminases /Acupuncture treatment in 60211
tution in HIV-1 reverse transcriptase in regard to increased poly 11125
on-nucleoside reverse inhibitor (S-1153) for the tre 12214
V) + nucleoside reverse inhibitors (NRTIs) in HIV-inf 12248
pretreated with reverse inhibitors/Experiences in pr 12340
wo nucleoside reverse inhibitors (NRTIs) in HIV inf 12350
ariants in HIV-1 reverse /Cytotoxic T lymphocytes ( 31137
he same HIV-1 reverse is compatible with enzyme a 32300
on-nucleoside reverse inhibitor after prolonged fail 32308
ns in the HIV-1 reverse (RT) gene and its predictive 32311
ompliance with reverse inhibitors or combination th 32399
duct enhanced reverse assay/Quantitation of HIV- 41137
notyping HIV-1 reverse to detect AZT-resistant mut 41143
nonnucleoside reverse inhibitor of HIV-1/S-1153, a 553*/41181
ison with other reverse inhibitors/The entry of 1592 41192
ysis of plasma reverse activity/Rapid phenotypic d 41209
4V mutation in reverse (RT) shows increased sensi 41214
nfection/HIV-1 reverse inhibition associated antibo 42115
hibitor (PI) and reverse inhibitor (RTI) concentration 42277
NRS053 trial)/Reverse and protease genotypes in 60316
sis of the HIV-1 reverse gene using differential hybri 60317
ibition of HIV-1 reverse transcription by actinomycin D (Act D): A 376*/11124
ine mRNAs by reverse /competitive PCR using a ne 21177
by multi-target reverse (RT)-linked polymerase chai 41139
by multi-target reverse (RT)-linked polymerase chai 42134
nal cell-associated viral transcriptional activity and the level of se 279*/11151
prevention programs/A transdisciplinary approach to AIDS preve 14294
cr5A32/Mechanism of transdominant inhibition of CCR5-mediat 54*/11105
ceptor complex/Signal transduction due to HIV-1 envelope intera 21140
Vagm Env and selective of primary human CD4+ T-c 41245
se: HIV-T Group (Blood Transfused )/Canada's blood tragedy, a c 44281
s at the National Blood Transfusion Center (NBTC) in Abidjan/Ps 60220
HIV-1 in a dual-infected transfusion recipient/Escape recombinan 11183
IV-1 in a dually-infected recipient/Escape recombinan 11199
s in blood handling and in the context of HIV/AIDS in 23258
France/Residual risk of -transmitted viral infections (H 33199
hes towards safer blood!/India marches towards safer 33208
m and changes in blood practices in the wake of HIV/A 42119
lishing a national blood service the Zambian experien 43217
Training for "Safe blood" in sub-Saharan Africa/Trainin 43567
infection through blood administrated in Japan/HIV in 60584
ed with HIV-1 via blood: Health status, 13 to 16 yrs aft 60789
cardiac surgery - Blood /Clinical relevance of "window 60921

itted by repeated blood transfusions among thalassemic children 23264
utologous and allogenic /Incidence of post-transfusio 42464
reality/The Portuguese transgender community: An unknown real 573*/43267
ence of HIV infection in transgendered individuals in San Francis 23536
wledge and risk among people in Philadelphia/HI 23553
A needs assessment of people and HIV/AIDS in Q 24160
riences of HIV-positive persons can influence adh 32395

- Keyword Abstract --
and HIV- incarcerated community/The health ca 572*/43417
pport program targeting inmates in 4 French prison 43418
concept of HIV-positive persons intervenes in HIV 60309
resentation/Mobilizing transgenders for HIV prevention through 574*/23530
program carried out by targeting transgenders: Imp 34138
vention program to MtF in Hollywood, CA/A commu 43305
T cell apoptosis in mice transgenic for HIV-1 Vpr/T cell apoptosis i 11142
hers sexual/parenteral transmissible pathogens in Brazil/Preval 22195
apprentices on sexually diseases (STD/AIDS)/Trai 60756
stered with an Sexually Transmitted Diseases (STD) center/Infor 33310
HIV and other sexually transmitted infections: Lower risk in lake-i 13119
ho highlands/Sexually diseases and HIV infection in 13123
men attending sexually disease (STD)/anonymous HI 13152
el networks of sexually diseases (STD) patients, 199 13180
g persons with sexually diseases (STD) in Italy betwe 520*/13281
ublic/Trends in sexually diseases in the Czech Republ 13287
of markers for sexually diseases in a male population 13289
of HIV infected sexually disease (STD) clinic attendee 13290
ents attending sexually disease clinics in Kuwait, 199 13291
ct of training in sexually diseases (STD) quality care t 13475
educe STD (sexually disease) risk behaviour amon 40*/14253
by clients with sexually diseases (STD) in Nairobi-Ke 14306
atients with sexually diseases attending a STD clin 22201
presenting to a sexually disease (STD) clinic in Los An 22205
Prevalence of sexually pathogens and Candida albic 22208
on Yaounde's sexually diseases's (STDs) clinic's atte 22209
n in Mexico City/Sexual diseases (STDs) incidence in 22210
Paulo, Brazil/Sexually diseases (STD) and HIV infec 23140
) among male sexually disease (STD) clinic attendee 23158
ospitals/HCV and HIV by repeated blood transfusion 23264
fect of treating sexually diseases (STDs) on HIV trans 526*/23369
ons (RTIs) and sexually diseases (STDs)/Community 23381
e E being more readily sexually than subtype B-Thai 23395
nowledge of sexually diseases in a South African m 23415
n consulted at sexually diseases (STD) clinics in Fort 23498
ents attending sexually diseases (STD) clinics in the 31197
ogens causing sexually diseases/Efficacy of a gel for 33123
n at low risk of sexually diseases for HIV prevention/ 33138
ction by other sexually disease pathogens/PRO 200 33146
dual risk of transfusion- viral infections (HIV and other 33199
ality of care for sexually diseases (STD) in Morocco b 33226
rkers reduces sexually infections/A voucher scheme 33228
n of the quality of sexual disease (STD) case manage 33232
asymptomatic sexually infections?/What role for routi 33247
tices amongst sexually diseases subjects/Impact of c 33283
Perceptions of sexually diseases (STDs) and treatme 33342
AIDS and other sexually infections through peer educa 33597
enotypic prevalence of ZDV- and ddl-resistant HIV-1 41210
ality of care for sexually infections - Methodological is 42221
nfection and sexually diseases and increase in con 182*/43236
ion) project of sexually diseases (STD) and AIDS pre 43386
populations of sexually diseases (STD) patients/Eval 43426
e integration of sexually diseases (STD) case manage 43530
-based clinic/Sexually disease (STD) in clients infect 44249
udes towards sexually diseases (STDs) and their pre 60004
unities/AIDS, sexually diseases and risk behaviours: 60138
omen/HIV and sexually disease educational program 60223
chi/Pattern of sexually diseases at a referral center o 60243
n on control of sexually disease (STDs) among sterili 60347
s in preventing sexually diseases/Female condoms a 60730
ital in Malawi/Sexually diseases in victims of rape the 60803
Prevalence of sexually infections including HIV amon 60860
management of sexually diseases/Training package f 60881
m/The use of sexually disease (STD) diagnosis and 60892
d prevention of sexually diseases among Nigerian ado 60906
Perception of the risk of transmitting HIV among people living with 23521
nfected patients versus transplant recipients under Ganciclovir th 31202
a/HIV infection in renal recepients in South India/HIV i 60233
our years after thymic transplantation in an AIDS patient/Succe 22421
ogeneic porcine thymic for the treatment of AIDS/ 41232
AIDS as a transitioning transsexual woman/Implications of living 569*/14208
e/HIV infection among sex workers from developing 570*/23534
ing impoverished HIV+ sex workers to HIV medical c 571*/44225

bian female, male, and sex workers in Rome/HIV inf 60258
s of Maori gay men and transsexuals who live in Sydney/Respon 402*/14220
gramme for the gay and /Unique STDs HIV/AIDS pro 23143
luation of oral mucosal transudate-based HIV testing/New testin 43106
each amongst the Hijra ( transvestite ) community of Peshawar, Pa 23342
IDS prevention among sex workers and other gay m 404*/44146
behaviour among male transvestites in Jakarta, Indonesia/HIV pr 23131